Skip to main content

Advertisement

SpringerLink
Log in

Cancer, Cardiovascular Disease, and Body Weight: a Complex Relationship

  • Obesity and Diet (G. Rao, Section Editor)
  • Published:
Current Cardiovascular Risk Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Cardiovascular disease is the leading cause of death in the United States. Obese patients are at an increased risk of cardiovascular disease and weight loss can attenuate the risk. Cancer is the second leading cause of death and commonly associated with weight loss. This review focuses on the complex interaction between body weight, cardiovascular disease, and a cancer diagnosis.

Recent Findings

The cancer-associated mortality rate has steadily decreased over the last decade. Patients are living longer. Therefore, nonmalignant conditions, such as cardiovascular disease, have assumed an increased importance in cancer survivors. Moreover, patients with cancer are at an especially high risk for cardiovascular disease, due to side effects of various treatments and overlapping risk factors for both malignancy and heart disease. In cancers with a high likelihood of survival or cure, cardiovascular screening, risk factor modification, and attentive treatment of cardiovascular problems should be vigilantly pursued.

Summary

Like all individuals, patients with cancer should strive to maintain a healthy weight and participate in regular physical activity, with a goal to optimize cardiac health and health span. Weight loss has a cardioprotective effect in cancer survivors without obvious cancer progression. The notion that cardiac health is a low priority for cancer survivors, particularly for patients with a favorable prognosis, is not true. However, in advanced stages of cancer or with highly lethal cancers, weight loss is associated with poor outcomes and nutritional support to optimize nutritional status and maintain body weight should be prioritized.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, et al. Heart disease and stroke statistics-2020 update: a report from the American Heart Association. Circulation. 2020;141:139–596.

    Google Scholar 

  2. Heart disease facts [Internet]. Centers for disease control and prevention. [cited 2020 Mar 25]. Available from: https://www.cdc.gov/heartdisease/facts.htm

  3. Wilson PWF, D’Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med [Internet]. 2002;162(16):1867–72. https://doi.org/10.1001/archinte.162.16.1867.

    Article  Google Scholar 

  4. Ortega FB, Lavie CJ, Blair SN. Obesity and cardiovascular disease. Circ Res. 2016;118(11):1752–70.

    CAS  PubMed  Google Scholar 

  5. Van Gaal LF, Mertens IL, de Block CE. Mechanisms linking obesity with cardiovascular disease. Nature. 2006;444:875–80.

    PubMed  Google Scholar 

  6. Kashima T. Obesity and cardiovascular diseases. IRYO - Japanese J Natl Med Serv. 1998;52(1):3–7.

    CAS  Google Scholar 

  7. Bastien M, Poirier P, Lemieux I, Després JP. Overview of epidemiology and contribution of obesity to cardiovascular disease. Prog Cardiovasc Dis. 2014;56(4):369–81.

    PubMed  Google Scholar 

  8. Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss. Circulation. 2006;113:898–918.

    PubMed  Google Scholar 

  9. Kochanek KD, Murphy SL, Xu J, Deaths AE. Deaths: final data for 2017. Natl Vital Stat Rep. 2019;68(9):1–78.

  10. Zhao Y, BY-M Y, Liu Y, Tong T, Liu Y. Weight reduction and cardiovascular benefits: protocol for a systematic review and meta-analysis. Medicine (Baltimore). 2018;97(50):e13246.

    Google Scholar 

  11. Hooper L, Martin N, Abdelhamid A, Davey Smith G. Reduction in saturated fat intake for cardiovascular disease. Cochrane Database Syst Rev. 2020, Issue 5. Art. No.: CD011737; https://doi.org/10.1002/14651858.CD011737.pub2.

  12. Brown JD, Buscemi J, Milsom V, Malcolm R, O’Neil PM. Effects on cardiovascular risk factors of weight losses limited to 5–10%. Transl Behav Med. 2016;6:339–46.

    PubMed  Google Scholar 

  13. Siegel RL, Miller KD, Jemal A. Cancer statistics. CA Cancer J Clin. 2020;70(1):7–30.

    PubMed  Google Scholar 

  14. Genkinger JM, Spiegelman D, Anderson KE, Bernstein L, van den Brandt PA, Calle EE, et al. A pooled analysis of 14 cohort studies of anthropometric factors and pancreatic cancer risk. Int J Cancer. 2011;129(7):1708–17.

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Hoyo C, Cook MB, Kamangar F, Freedman ND, Whiteman DC, Bernstein L, et al. Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium. Int J Epidemiol. 2012;41(6):1706–18.

    PubMed  PubMed Central  Google Scholar 

  16. Chen Y, Liu L, Wang X, Wang J, Yan Z, Cheng J, et al. Body mass index and risk of gastric cancer: a meta-analysis of a population with more than ten million from 24 prospective studies. Cancer Epidemiol Biomark Prev. 2013;22(8):1395–408.

    Google Scholar 

  17. Wang F, Xu Y. Body mass index and risk of renal cell cancer: a dose-response meta-analysis of published cohort studies. Int J Cancer [Internet]. 2014;135(7):1673–86. https://doi.org/10.1002/ijc.28813.

    Article  CAS  Google Scholar 

  18. Campbell PT, Newton CC, Freedman ND, Koshiol J, Alavanja MC, Beane Freeman LE, et al. Body mass index, waist circumference, diabetes, and risk of liver cancer for U.S. adults. Cancer Res. 2016;76(20):6076–83.

    CAS  PubMed  PubMed Central  Google Scholar 

  19. Wong CJ. Involuntary weight loss. Med Clin N Am. 2014;98:625–43.

    PubMed  Google Scholar 

  20. Marton KI, Sox HC Jr, Krupp J. Involuntary weight loss: diagnostic and prognostic significance. Ann Intern Med [Internet]. 1981;95(5):568–74. https://doi.org/10.7326/0003-4819-95-5-568.

    Article  CAS  Google Scholar 

  21. Rabinovitz M, Pitlik SD, Leifer M, Garty M, Rosenfeld JB. Unintentional weight loss: a retrospective analysis of 154 cases. Arch Intern Med [Internet]. 1986;146(1):186–7. https://doi.org/10.1001/archinte.1986.00360130224029.

    Article  CAS  Google Scholar 

  22. Thompson MP, Morris LK. Unexplained weight loss in the ambulatory elderly. J Am Geriatr Soc. 1991;39:497–500.

    CAS  PubMed  Google Scholar 

  23. Lankisch PG, Gerzmann M, Gerzmann JF, Lehnick D. Unintentional weight loss: diagnosis and prognosis. The first prospective follow-up study from a secondary referral centre. J Intern Med. 2001;249(1):41–6.

    CAS  PubMed  Google Scholar 

  24. Bilbao-Garay J, Barba R, Losa-García JE, Martín H, García de Casasola G, Castilla V, et al. Assessing clinical probability of organic disease in patients with involuntary weight loss: a simple score. Eur J Intern Med. 2002;13(4):240–5.

    CAS  PubMed  Google Scholar 

  25. Metalidis C, Knockaert DC, Bobbaers H, Vanderschueren S. Involuntary weight loss. Does a negative baseline evaluation pro- vide adequate reassurance? Eur J Intern Med. 2008;19(5):345–9.

    PubMed  Google Scholar 

  26. Wu JM, Lin MH, Peng LN, Chen LK, Hwang SJ. Evaluating diagnostic strategy of older patients with unexplained unintentional body weight loss: a hospital-based study. Arch Gerontol Geriatr. 2011;53:e51–4.

    PubMed  Google Scholar 

  27. Chen SP, Peng LN, Lin MH, Lai HY, Hwang SJ, Chen LK. Evaluating probability of cancer among older people with unex- plained, unintentional weight loss. Arch Gerontol Geriatr. 2010;50(suppl 1):S27–9.

    PubMed  Google Scholar 

  28. Tan BHL, Fearon KCH. Cachexia: Prevalence and impact in medicine. Curr Opin Clin Nutr Metab Care. 2008;11(4):400–7.

    PubMed  Google Scholar 

  29. Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. East Cooperat Oncol Group Am J Med. 1980;69(4):491–7.

    CAS  Google Scholar 

  30. Hamilton W, Lancashire R, Sharp D, Peters TJ, Cheng KK, Marshall T. The risk of colorectal cancer with symptoms at dif- ferent ages and between the sexes: a case-control study. BMC Med. 2009;7:17.

    PubMed  PubMed Central  Google Scholar 

  31. Walter V, Jansen L, Hoffmeister M, Ulrich A, Roth W, Bläker H, et al. Prognostic relevance of prediagnostic weight loss and overweight at diagnosis in patients with colorectal cancer. Am J Clin Nutr. 2016;104:1110–20.

    CAS  PubMed  Google Scholar 

  32. Kroenke CH, Neugebauer R, Meyerhardt J, Prado CM, Weltzien E, Kwan ML, et al. Analysis of body mass index and mortality in patients with colorectal cancer using causal diagrams. JAMA Oncol. 2016;2(9):1137–45.

    PubMed  PubMed Central  Google Scholar 

  33. van Zutphen M, Geelen A, Boshuizen HC, Winkels RM, Geijsen AJMR, Wesselink E, et al. Pre-to-post diagnosis weight trajecto- ries in colorectal cancer patients with non-metastatic disease. Support Care Cancer. 27(4):1541–9.

  34. Shen S, Araujo JL, Altorki NK, Sonett JR, Rodriguez A, Sungur- Stasik K, et al. Variation by stage in the effects of prediagnosis weight loss on mortality in a prospective cohort of esophageal cancer patients. Dis Esophagus. 2017;30(9):1–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  35. Yu XL, Yang J, Chen T, Liu YM, Xue WP, Wang MH, et al. Excessive pretreatment weight loss is a risk factor for the survival outcome of esophageal carcinoma patients undergoing radical surgery and postoperative adjuvant chemotherapy. Can J Gastroenterol Hepatol. 2018;2018:6075207.

    PubMed  PubMed Central  Google Scholar 

  36. Sahin C, Omar M, Tunca H, Kalemci S, Ozseker B, Akbaba G, et al. Weight loss at the time of diagnosis is not associated with prognosis in patients with advanced-stage non-small cell lung cancer. J BUON. 2015;20(6):1576–84.

    PubMed  Google Scholar 

  37. Morel H, Raynard B, d’Arlhac M, Hauss P-A, Lecuyer E, Oliviero G, et al. Prediagnosis weight loss, a stronger factor than BMI, to predict survival in patients with lung cancer. Lung Cancer [Internet]. 2018;126:55–63. https://doi.org/10.1016/j.lungcan.2018.07.005.

    Article  Google Scholar 

  38. Wigmore SJ, Plester CE, Richardson RA, Fearon KCH. Changes in nutritional status associated with unresectable pancreatic cancer. Br J Cancer. 1997;75(1):106–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  39. Olson SH, Xu Y, Herzog K, Saldia A, Defilippis EM, Li P, et al. Weight loss, diabetes, fatigue, and depression preceding pancreatic cancer. Pancreas. 2016;45(7):986–91.

    PubMed  PubMed Central  Google Scholar 

  40. Hendifar AE, Chang JI, Huang BZ, Tuli R, Wu BU. Cachexia, and not obesity, prior to pancreatic cancer diagnosis worsens survival and is negated by chemotherapy. J Gastrointest Oncol. 2018;9(1):17–23.

    PubMed  PubMed Central  Google Scholar 

  41. Nemer L, Krishna SG, Shah ZK, Conwell DL, Cruz-Monserrate Z, Dillhoff M, et al. Predictors of pancreatic cancer-associated weight loss and nutritional interventions. Pancreas. 2017;46(9):1152–7.

    PubMed  PubMed Central  Google Scholar 

  42. Cleveland RJ, Eng SM, Abrahamson PE, Britton JA, Teitelbaum SL, Neugut AI, et al. Weight gain prior to diagnosis and survival from breast cancer. Cancer Epidemiol Biomark Prev. 2007;16(9):1803–11.

    Google Scholar 

  43. Dutton GR, Kim Y, Jacobs DR, Li X, Loria CM, Reis JP, et al. 25-year weight gain in a racially balanced sample of U.S. adults: The CARDIA study. Obesity. 2016;24(9):1962–8.

    PubMed  Google Scholar 

  44. Ravasco P. Nutrition in Cancer Patients. J Clin Med. 2019;8(8):1211.

    CAS  PubMed Central  Google Scholar 

  45. Mantzorou M, Koutelidakis A, Theocharis S, Giaginis C. Clinical value of nutritional status in cancer: what is its impact and how it affects disease progression and prognosis? Nutr Cancer. 2017;69(8):1151–76.

    PubMed  Google Scholar 

  46. Ross PJ, Ashley S, Norton A, Priest K, Waters JS, Eisen T, et al. Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers? Br J Cancer. 2004;90(10):1905–11.

    CAS  PubMed  PubMed Central  Google Scholar 

  47. Kiss N, Isenring E, Gough K, Krishnasamy M. The prevalence of weight loss during (chemo)radiotherapy treatment for lung cancer and associated patient - and treatment-related factors. Clin Nutr. 2014;33(6):1074–80.

    PubMed  Google Scholar 

  48. Andreyev HJN, Norman AR, Oates J, Cunningham D. Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur J Cancer. 1998;34(4):503–9.

    CAS  PubMed  Google Scholar 

  49. Morita Y, Sakaguchi T, Kitajima R, Furuhashi S, Kiuchi R, Takeda M, et al. Body weight loss after surgery affects the continuity of adjuvant chemotherapy for pancreatic cancer. BMC Cancer. 2019;19(1):416.

    PubMed  PubMed Central  Google Scholar 

  50. Ock C-Y, Oh D-Y, Lee J, Kim T-Y, Lee K-H, Han S-W, et al. Weight loss at the first month of palliative chemotherapy predicts survival outcomes in patients with advanced gastric cancer. Gastric Cancer [Internet]. 2016;19(2):597–606. https://doi.org/10.1007/s10120-015-0481-4.

    Article  CAS  Google Scholar 

  51. Kindler HL, Niedzwiecki D, Hollis D, Sutherland S, Schrag D, Hurwitz H, et al. Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303). J Clin Oncol. 2010;28(22):3617–22.

    CAS  PubMed  PubMed Central  Google Scholar 

  52. Prigerson HG, Bao Y, Shah MA, Paulk ME, LeBlanc TW, Schneider BJ, et al. Chemotherapy Use, Performance Status, and Quality of life at the end of life. JAMA Oncol [Internet]. 2015;1(6):778–84. https://doi.org/10.1001/jamaoncol.2015.2378.

    Article  Google Scholar 

  53. Atalay C, Küçük Aİ. The impact of weight gain during adjuvant chemotherapy on survival in breast cancer. Ulus cerrahi Derg. 2015;31(3):124–7.

    PubMed  PubMed Central  Google Scholar 

  54. van den Berg MMGA, Winkels RM, de Kruif JTCM, van Laarhoven HWM, Visser M, de Vries JHM, et al. Weight change during chemotherapy in breast cancer patients: a meta-analysis. BMC Cancer. 2017;17(1):259.

    PubMed  PubMed Central  Google Scholar 

  55. Climent M, Munarriz M, Blazeby JM, Dorcaratto D, Ramón JM, Carrera MJ, et al. Weight loss and quality of life in patients surviving 2 years after gastric cancer resection. Eur J Surg Oncol. 2017;43:1337–43.

    CAS  PubMed  Google Scholar 

  56. Davis JL, Selby LV, Chou JF, Schattner M, Ilson DH, Capanu M, et al. Patterns and predictors of weight loss after gastrectomy for cancer. Ann Surg Oncol. 2016;23:1639–45.

    PubMed  PubMed Central  Google Scholar 

  57. Kitagawa H, Namikawa T, Munekage M, Fujisawa K, Munekage E, Kawanishi Y, et al. Analysis of factors associated with weight loss after esophagectomy for esophageal cancer. Anticancer Res. 2016;36(10):5409–12.

    PubMed  Google Scholar 

  58. Cloyd JM, Nogueras-González GM, Prakash LR, Petzel MQB, Parker NH, Ngo-Huang AT, et al. Anthropometric changes in patients with pancreatic cancer undergoing preoperative therapy and pancreatoduodenectomy. J Gastrointest Surg. 2018;22(4):703–12.

    PubMed  Google Scholar 

  59. Gilliland TM, Villafane-Ferriol N, Shah KP, Shah RM, Tran Cao HS, Massarweh NN, et al. Nutritional and metabolic derange-ments in pancreatic cancer and pancreatic resection. Nutrients. 2017;9(3):243.

    PubMed Central  Google Scholar 

  60. Hashimoto D, Chikamoto A, Ohmuraya M, Abe S, Nakagawa S, Beppu T, et al. Impact of postoperative weight loss on survival after resection for pancreatic cancer. J Parenter Enter Nutr. 2015;39:598–603.

    Google Scholar 

  61. Aoyagi T, Terracina KP, Raza A, Matsubara H, Takabe K. Cancer cachexia, mechanism and treatment. World J Gastrointest Oncol. 2015;7(4):17–29.

    PubMed  PubMed Central  Google Scholar 

  62. Bruggeman AR, Kamal AH, Le Blanc TW, Ma JD, Baracos VE, Roeland EJ. Cancer cachexia: beyond weight loss. J Oncol Pract. 2016;12(11):1163–71.

    PubMed  Google Scholar 

  63. Advani SM, Advani PG, VonVille HM, Jafri SH. Pharmacological management of cachexia in adult cancer patients: a systematic review of clinical trials. BMC Cancer [Internet]. 2018;18(1):1174. https://doi.org/10.1186/s12885-018-5080-4.

    Article  CAS  Google Scholar 

  64. Dunne RF, Loh KP, Williams GR, Jatoi A, Mustian KM, Mohile SG. Cachexia and sarcopenia in older adults with cancer: a comprehensive review. Cancers (Basel). 2019;11(12):1861.

    Google Scholar 

  65. Levolger S, Van Vugt JLA, De Bruin RWF, IJzermans JNM. Systematic review of sarcopenia in patients operated on for gas- trointestinal and hepatopancreatobiliary malignancies. Br J Surg. 2015;102(12):1448–58.

    CAS  PubMed  Google Scholar 

  66. Psutka SP, Carrasco A, Schmit GD, Moynagh MR, Boorjian SA, Frank I, et al. Sarcopenia in patients with bladder cancer undergoing radical cystectomy: impact on cancer-specific and all-cause mortality. Cancer. 2014;120:2910–8.

    PubMed  Google Scholar 

  67. Lieffers JR, Bathe OF, Fassbender K, Winget M, Baracos VE. Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. Br J Cancer. 2012;107:931–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  68. Pamoukdjian F, Bouillet T, Lévy V, Soussan M, Zelek L, Paillaud E. Prevalence and predictive value of pre-therapeutic sarcopenia in cancer patients: a systematic review. Clin Nutr. 2018;37:1101–13.

    PubMed  Google Scholar 

  69. Nakashima Y, Saeki H, Nakanishi R, Sugiyama M, Kurashige J, Oki E, et al. Assessment of sarcopenia as a predictor of poor outcomes after esophagectomy in elderly patients with esophageal cancer. Ann Surg. 2018;267(6):1100–4.

    PubMed  Google Scholar 

  70. Prado CMM, Baracos VE, LJ MC, Reiman T, Mourtzakis M, Tonkin K, et al. Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res. 2009;15(8):2920–6.

    CAS  PubMed  Google Scholar 

  71. Csapo M, Lazar L. Chemotherapy-induced cardiotoxicity: patho- physiology and prevention. Clujul Med. 2014;87(3):135–42.

    PubMed  PubMed Central  Google Scholar 

  72. Yeh ETH, Bickford CL. Cardiovascular complications of cancer therapy. J Am Coll Cardiol. 2009;53:2231–47.

    CAS  PubMed  Google Scholar 

  73. Yeh ETH, Tong AT, Lenihan DJ, Yusuf SW, Swafford J, Champion C, et al. Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management. Circulation. 2004;109(25):3122–31.

    PubMed  Google Scholar 

  74. Yusuf SW, Venkatesulu BP, Mahadevan LS, Krishnan S. Radiation-induced cardiovascular disease: a clinical perspective. Front Cardiovasc Med. 2017;4:66.

    PubMed  PubMed Central  Google Scholar 

  75. • Schultz PN, Beck ML, Stava C, Vassilopoulou-Sellin R. Health profiles in 5836 long-term cancer survivors. Int J Cancer. 2003;104(4):488–95 Schultz et al. provide a thorough analysis of health profiles in several thousand patients with a variety of different cancers. They demonstrate that patients with different cancer types experience long-term health problems at varying rates, which change over time, amd compare the frequency of new-onset health problems to the general population. They conclude that greater emphasis should be placed on long-term medical care among cancer survivors.

    CAS  PubMed  Google Scholar 

  76. Enright KA, Krzyzanowska MK. Control of cardiovascular risk factors among adult cancer survivors: a population-based survey. Cancer Causes Control. 2010;21(11):1867–74.

    CAS  PubMed  Google Scholar 

  77. Hawkes AL, Lynch BM, Owen N, Aitken JF. Lifestyle factors associated concurrently and prospectively with co-morbid cardiovascular disease in a population-based cohort of colorectal cancer survivors. Eur J Cancer. 2011;47(2):267–76.

    PubMed  Google Scholar 

  78. •• Sturgeon KM, Deng L, Bluethmann SM, Zhou S, Trifiletti DM, Jiang C, et al. A population-based study of cardiovascular disease mortality risk in US cancer patients. Eur Heart J. 2019;40(48):3889–97 Sturgeon et al. utilize a national database to characterize the relationship between cardiovascular disease and multiple different types of cancer. They demonstrate that patients with less aggressive cancers (breast, prostate, bladder) are at highest risk of a cardiovascular mortality.

    PubMed  PubMed Central  Google Scholar 

  79. Ganz PA. Survivorship: adult cancer survivors. Prim Care. 2009;36(4):721–41.

    PubMed  Google Scholar 

  80. Roy S, Vallepu S, Barrios C, Hunter K. Comparison of comorbid conditions between cancer survivors and age-matched patients without cancer. J Clin Med Res. 2018;10(12):911–9.

    PubMed  PubMed Central  Google Scholar 

  81. Patnaik JL, Byers T, DiGuiseppi C, Dabelea D, Denberg TD. Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study. Breast Cancer Res. 2011;13(3):R64.

    PubMed  PubMed Central  Google Scholar 

  82. Chapman JAW, Meng D, Shepherd L, Parulekar W, Ingle JN, Muss HB, et al. Competing causes of death from a randomized trial of extended adjuvant endocrine therapy for breast cancer. J Natl Cancer Inst. 2008.

  83. Satariano WA, Ragland DR. The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med. 1994;120:104–10.

    CAS  PubMed  Google Scholar 

  84. Felix AS, Bower JK, Pfeiffer RM, Raman SV, Cohn DE, Sherman ME. High cardiovascular disease mortality after endometrial cancer diagnosis: results from the surveillance, epidemiology, and end results (SEER) database. Int J Cancer. 2017;140(3):555–64.

    CAS  PubMed  Google Scholar 

  85. Mertens AC, Liu Q, Neglia JP, Wasilewski K, Leisenring W, Armstrong GT, et al. Cause-specific late mortality among 5-year survivors of childhood cancer: the childhood cancer survivor study. J Natl Cancer Inst. 2008;100(19):1368–79.

    PubMed  PubMed Central  Google Scholar 

  86. • Lyon AR, Habibian M, Evertz R, Asteggiano R, Suter T. Diagnosis and treatment of left ventricular dysfunction and heart failure in cancer patients. Cardiol Pract. 2019;16(40) Lyon et al. provide a comprehensive evidence-based overview of surveillance and treatment strategies of cancer patients who develop cardiovascular disease.

  87. Rafiyath SM, Rasul M, Lee B, Wei G, Lamba G, Liu D. Comparison of safety and toxicity of liposomal doxorubicin vs. conventional anthracyclines: a meta-analysis. Exp Hematol Oncol [Internet]. 2012;1(1):10. https://doi.org/10.1186/2162-3619-1-10.

    Article  CAS  Google Scholar 

  88. Daher IN, Daigle TR, Bhatia N, Durand JB. The prevention of cardiovascular disease in cancer survivors. Texas Hear Inst J. 2012;39(2):190–8.

    Google Scholar 

  89. Rafiyath SM, Rasul M, Lee B, Wei G, Lamba G, Liu D. Comparison of safety and toxicity of liposomal doxorubicin vs. conventional anthracyclines: a metaanalysis. Exp Hematol Oncol. 2012;1(1):10.

    CAS  PubMed  PubMed Central  Google Scholar 

  90. Wolin KY, Dart H, Colditz GA. Eight ways to stay healthy after cancer: an evidence-based message. Cancer Causes Control. 2013;24(5):827–37.

    PubMed  PubMed Central  Google Scholar 

  91. Weaver KE, Foraker RE, Alfano CM, Rowland JH, Arora NK, Bellizzi KM, et al. Cardiovascular risk factors among long-term survivors of breast, prostate, colorectal, and gynecologic cancers: a gap in survivorship care? J Cancer Surviv. 2013;7(2):253–61.

    PubMed  PubMed Central  Google Scholar 

  92. Kroenke CH, Chen WY, Rosner B, Holmes MD. Weight, weight gain, and survival after breast cancer diagnosis. J Clin Oncol. 2005.

  93. Dignam JJ, Polite BN, Yothers G, Raich P, Colangelo L, O’Connell MJ, et al. Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer. J Natl Cancer Inst. 2006;98(22):1647–54.

    PubMed  Google Scholar 

  94. Mefferd K, Nichols JF, Pakiz B, Rock CL. A cognitive behavioral therapy intervention to promote weight loss improves body composition and blood lipid profiles among overweight breast cancer survivors. Breast Cancer Res Treat. 2007;104(2):145–52.

    PubMed  Google Scholar 

  95. Befort CA, Klemp JR, Austin HL, Perri MG, Schmitz KH, Sullivan DK, et al. Outcomes of a weight loss intervention among rural breast cancer survivors. Breast Cancer Res Treat. 2012;132(2):631–9.

    PubMed  Google Scholar 

  96. Greenlee HA, Crew KD, Mata JM, McKinley PS, Rundle AG, Zhang W, et al. A pilot randomized controlled trial of a commercial diet and exercise weight loss program in minority breast cancer survivors. Obesity (Silver Spring). 2013;21(1):65–76.

    CAS  Google Scholar 

  97. •• Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, et al. ESPEN guidelines on nutrition in cancer patients. Clin Nutr [Internet]. 2017;36(1):11–48. https://doi.org/10.1016/j.clnu.2016.07.015Arends el at. provide clinical guidelines for nutrition in cancer patients. These guidelines are evidence based and provide a comprehensive overview to help optimize a patient's nutrition status.

    Article  Google Scholar 

  98. Herrmann J, Loprinzi C, Ruddy K. Building a cardio-onco-hematology program. Curr Oncol Rep. 2018;20(10):81.

    PubMed  Google Scholar 

  99. Baldwin C, Spiro A, Ahern R, Emery PW. Oral nutritional interventions in malnourished patients with cancer: a systematic review and meta-analysis. J Natl Cancer Inst. 2012;104(5):371–85.

    PubMed  Google Scholar 

  100. Klement RJ. Beneficial effects of ketogenic diets for cancer patients: a realist review with focus on evidence and confirmation. Med Oncol. 2017;34(8):132.

    PubMed  Google Scholar 

  101. Schmidt M, Pfetzer N, Schwab M, Strauss I, Kämmerer U. Effects of a ketogenic diet on the quality of life in 16 patients with advanced cancer: a pilot trial. Nutr Metab. 2011;8:54.

    CAS  Google Scholar 

  102. Jones LW, Alfano CM. Exercise-oncology research: past, present, and future. Acta Oncol. 2013.

Download references

Funding

Dr. Jordan M. Winter received grant support from NIH/NCI R37CA227865-01A1.

Author information

Authors and Affiliations

  1. Division of Surgical Oncology, Department of Surgery, Seidman Cancer Center, University Hospitals Cleveland Medical Center, 11100 Euclid Ave, Cleveland, OH, 44106, USA

    Jonathan J. Hue & Jordan M. Winter

Authors
  1. Jonathan J. Hue
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jordan M. Winter
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jordan M. Winter.

Ethics declarations

Conflict of Interest

Jonathan Hue and Jordan Winter declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Obesity and Diet

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hue, J.J., Winter, J.M. Cancer, Cardiovascular Disease, and Body Weight: a Complex Relationship. Curr Cardiovasc Risk Rep 14, 27 (2020). https://doi.org/10.1007/s12170-020-00660-6

Download citation

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12170-020-00660-6

Keywords

Search

Navigation